IFF Sells Natural Ingredients Portfolio to SuanNutra as Ingredients M&A Heats Up

Wednesday 07/27/2026 – International Flavors & Fragrances (IFF) is shedding another piece of its portfolio. The flavor and fragrance giant has agreed to sell its natural colors and functional ingredients business to SuanNutra, a nutraceutical company backed by Carbyne Equity Partners, in a transaction announced on July 22, 2026. Financial terms were not disclosed, and the companies expect the deal to close before the end of the year.

The divestiture is the latest move in IFF's ongoing effort to streamline its operations and sharpen its focus on core, higher-margin categories — and it lands in the middle of one of the busiest stretches of dealmaking the ingredients industry has seen in years.

What's Included in the IFF–SuanNutra Deal

The assets changing hands span a broad slice of IFF's specialty natural ingredients operations. The package covers botanical extracts, vitamins and minerals, and food enhancement products, along with the company's natural colors and antioxidant lines. Five manufacturing sites — located across the United States, Europe, and Latin America — are also part of the transaction.

While the purchase price was not made public, the business is not a trivial one: IFF reported that these operations brought in roughly $170 million in revenue last year.

For SuanNutra, the acquisition represents a significant scale-up. The company specializes in nutraceuticals — ingredients positioned at the intersection of food and health — and adding IFF's botanical and functional ingredient assets gives it a much deeper bench of science-backed products to offer food, beverage, and supplement manufacturers. Yoni Glickman, SuanNutra's non-executive chairman, framed the purchase as a bet on where the market is going, saying that <cite index="1-1">"clinically supported branded ingredients are where this industry is heading."</cite>

Carbyne Equity Partners, SuanNutra's owner, echoed that logic, positioning the deal as a play on the food industry's broad migration away from synthetic dyes, preservatives, and artificial flavors toward natural, clean-label alternatives.

Part of a Larger IFF Slim-Down

The SuanNutra transaction doesn't stand alone. Just two months earlier, in May 2026, IFF struck a much larger agreement to sell its food ingredients business to private equity firm CVC Capital Partners for $4.3 billion — a move the company said was aimed at improving profitability.

Taken together, the two sales signal a clear strategic direction. IFF, which ballooned in size after its 2021 merger with DuPont's nutrition and biosciences unit, has spent recent years working to pay down debt and unwind parts of that sprawling portfolio. Divesting lower-margin or non-core ingredient lines allows the company to concentrate resources on its flagship flavors, fragrances, and scent businesses, where it holds some of its strongest competitive positions.

Why Ingredients M&A Is Surging

The IFF–SuanNutra agreement arrives amid a remarkable run of consolidation across the ingredients sector. In addition to IFF's $4.3 billion food ingredients sale in May, Ingredion agreed to acquire longtime rival Tate & Lyle in a deal valued at $3.6 billion — two multibillion-dollar transactions reached within just a few months of each other.

Several forces are driving the frenzy:

Reformulation pressure. Major food manufacturers are racing to reformulate products, stripping out artificial colors and additives in response to both consumer demand and mounting regulatory scrutiny of synthetic dyes. That has made suppliers of natural colors, botanical extracts, and clean-label functional ingredients unusually attractive acquisition targets.

The health and wellness boom. Shoppers are increasingly scanning labels for ingredients they recognize and for products that promise functional benefits — from gut health to immunity. Companies that own clinically validated, branded ingredients are positioned to command premium pricing.

Portfolio rationalization. Large diversified ingredients players like IFF are pruning their portfolios, creating a steady pipeline of assets for private equity firms and specialized buyers like SuanNutra to snap up.

What It Means for the Industry

For food and beverage manufacturers, the reshuffling of ingredient assets could ultimately change who they buy from — and what innovation looks like. Specialized owners like SuanNutra argue they can invest more aggressively in clinical research and branded ingredient platforms than a sprawling conglomerate juggling dozens of business lines.

For IFF, the sale marks another step toward a leaner company built around its most profitable segments. Investors will be watching whether the slimmed-down portfolio delivers the margin improvement management has promised.

And for the broader ingredients market, the message is unmistakable: the shift toward natural, clean-label, and clinically supported ingredients is no longer a niche trend. It's now the organizing principle behind billions of dollars in dealmaking — and with reformulation pressure showing no signs of easing, the IFF–SuanNutra deal is unlikely to be the last transaction of its kind in 2026.

###